Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 61 AL 75

Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease

Chatterjee P, Fernando M, Fernando B, Dias CB, Shah T, Silva R, Williams S, Pedrini S, Hillebrandt H, Goozee K, Barin E, Sohrabi HR, Garg M, Cunnane S, Martins RN.

Mech Ageing Dev. 2020 Mar;186:111209. doi: 10.1016/j.mad.2020.111209. Epub 2020 Jan 15.

Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data

Conrado DJ, Duvvuri S, Geerts H, Burton J, Biesdorf C, Ahamadi M, Macha S, Hather G, Francisco Morales J, Podichetty J, Nicholas T, Stephenson D, Trame M, Romero K, Corrigan B; Drug Development Tools in the Alzheimer Disease Continuum (DDT-AD) Working Group.

Clin Pharmacol Ther. 2020 Apr;107(4):796-805. doi: 10.1002/cpt.1782. Epub 2020 Mar 11.

Alzheimer's disease: review of current nanotechnological therapeutic strategies

Baranowska-Wójcik E, Szwajgier D.

Expert Rev Neurother. 2020 Mar;20(3):271-279. doi: 10.1080/14737175.2020.1719069. Epub 2020 Jan 27.

Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology

Tuzzi E, Balla DZ, Loureiro JRA, Neumann M, Laske C, Pohmann R, Preische O, Scheffler K, Hagberg GE.

J Alzheimers Dis. 2020;73(4):1481-1499. doi: 10.3233/JAD-190424.

Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus

Reeves BC, Karimy JK, Kundishora AJ, Mestre H, Cerci HM, Matouk C, Alper SL, Lundgaard I, Nedergaard M, Kahle KT.

Trends Mol Med. 2020 Mar;26(3):285-295. doi: 10.1016/j.molmed.2019.11.008. Epub 2020 Jan 18.

Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer's Disease

Birla H, Minocha T, Kumar G, Misra A, Singh SK.

Curr Neuropharmacol. 2020;18(7):552-562. doi: 10.2174/1570159X18666200122122512.

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease

Yoshida K, Moein A, Bittner T, Ostrowitzki S, Lin H, Honigberg L, Jin JY, Quartino A.

Alzheimers Res Ther. 2020 Jan 22;12(1):16. doi: 10.1186/s13195-020-0580-2.

Neuroinflammation and Neurogenesis in Alzheimer's Disease and Potential Therapeutic Approaches

Sung PS, Lin PY, Liu CH, Su HC, Tsai KJ.

Int J Mol Sci. 2020 Jan 21;21(3):701. doi: 10.3390/ijms21030701.

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics

Mouchlis VD, Melagraki G, Zacharia LC, Afantitis A.

Int J Mol Sci. 2020 Jan 21;21(3):703. doi: 10.3390/ijms21030703.

Caveolin: A New Link Between Diabetes and AD

Surguchov A.

Cell Mol Neurobiol. 2020 Oct;40(7):1059-1066. doi: 10.1007/s10571-020-00796-4. Epub 2020 Jan 23.

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease

Haake A, Nguyen K, Friedman L, Chakkamparambil B, Grossberg GT.

Expert Opin Drug Saf. 2020 Feb;19(2):147-157. doi: 10.1080/14740338.2020.1721456. Epub 2020 Jan 28.

Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study

Mahajan UV, Varma VR, Griswold ME, Blackshear CT, An Y, Oommen AM, Varma S, Troncoso JC, Pletnikova O, O'Brien R, Hohman TJ, Legido-Quigley C, Thambisetty M.

PLoS Med. 2020 Jan 24;17(1):e1003012. doi: 10.1371/journal.pmed.1003012. eCollection 2020 Jan.

Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease

Zuccarello E, Acquarone E, Calcagno E, Argyrousi EK, Deng SX, Landry DW, Arancio O, Fiorito J.

Biochem Pharmacol. 2020 Jun;176:113818. doi: 10.1016/j.bcp.2020.113818. Epub 2020 Jan 21.

Crosstalk between the M(1) muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?

Thompson KJ, Tobin AB.

Cell Signal. 2020 Jun;70:109545. doi: 10.1016/j.cellsig.2020.109545. Epub 2020 Jan 21.

Unraveling the complexity of γ-secretase

Wolfe MS.

Semin Cell Dev Biol. 2020 Sep;105:3-11. doi: 10.1016/j.semcdb.2020.01.005. Epub 2020 Jan 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias